SENSEX NIFTY
Jun 18, 2007, 07.26 PM IST | Source: CNBC-TV18

US-based CytImmune gears up to target cancer cure

We all know there is no magic bullet for cancer. But scientists across the world are working on novel projects like cancer vaccines and newer tools like nanotechnology to conquer cancer, reports CNBC-TV18.

US-based CytImmune gears up to target cancer cure

We all know there is no magic bullet for cancer . But scientists across the world are working on novel projects like cancer vaccines and newer tools like nanotechnology to conquer cancer, reports CNBC-TV18.
 
CytImmune is a small US-based nanotechnology company , but it has set a big goal for itself. CytImmune scientists are developing a nanotechnology-based Drug Delivery System that can target cancerous tumours leaving healthy organs and tissues untouched.

Dr Larry Tamarkin , CEO , Cytimmune, says, “These particles are especially designed with our proprietary technology.”
 
If all goes well in the human trials, CytImmune could provide leads to more precision-based cancer therapies. This is because most experts feel the biggest drawback of most anti-cancer drugs is that they tend to damage healthy tissues. These drugs may not really be targetted therapies as suggested by companies.

Several drug makers like Novartis , Merck and Genentech are also working on a few therapeutic vaccines that can induce the patients’ own immune system to act on the deadly cancer cells.

Elmar Schenny , CEO , Merck Germany , says, “It is in phase III and help attack tumours.”

With the help of genomics and proteomics, experts say over the next few years, it will be easier to see a real headway in predicting and curing cancer.

ADS BY GOOGLE

video of the day

Indian economy to see real turnaround in 6 mths: Madhu Kela

Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.